Oaktree Acquisition Corp. III Life Sciences
OACCW· Nasdaq
OACCWOaktree Acquisition Corp. III Life Sciences
Filed Aug 12, 2026 · 10-Q · 43 days after period end · 0001193125-26-346973
| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Net Income | $1.60M | $1.87M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oaktree Acquisition Corp. III Life Sciences · CIK 2029769 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 12, 2026 · 43 d after period end
